Madhav Naik’s Post

🤫Curious how you can bulletproof your CGT analytics? Find out more here and reach out to our experts!

ICYMI: Listen to Dr. Salvador Rico, CMO of Encoded Therapeutics Inc., discuss the company's gene therapy and overall program looking to tackle #DravetSyndrome https://lnkd.in/eZkjigEh #InternationalEpilepsyDay Dravet Syndrome Foundation

Rapid reviews, rapid results: Check out this case study to find out how Advarra’s collaboration facilitated speedy gene therapy research launches, ensuring the first patient/first visit was on time and within budget. Find out how you do it too in our case study: https://lnkd.in/eFtPk3zC

Rapid reviews, rapid results: Check out this case study to find out how Advarra’s collaboration facilitated speedy gene therapy research launches, ensuring the first patient/first visit was on time and within budget. Find out how you do it too in our case study: https://lnkd.in/gJak9R23

We guide you towards an oasis of reliable cell and gene therapy (CGT) analytics. Where assay translation from analytical development to quality control (QC), potency assay development, and assay validation become straightforward. #MiltenyiBiotec #drivingCGT Learn more: https://ow.ly/6ROV50RfVpu

Rapid reviews, rapid results: Check out this case study to find out how Advarra’s collaboration facilitated speedy gene therapy research launches, ensuring the first patient/first visit was on time and within budget. Find out how you do it too in our case study: https://lnkd.in/epaAcM8h

In this interactive roundtable—the first in a three-part series—our team discusses key opportunities, scientific innovations and insights driving acceleration of preclinical gene therapy programs to IND/CTA and beyond. Watch the roundtable here

Have you read our recently released target product profile (TPP) guide and want to learn more about how to develop an effective TPP for successful therapy adoption? Join our webinar on the 31st of January titled 'Developing a robust target product profile (TPP) for successful therapy adoption', where Cell and Gene Therapy Catapult’s experts in #MarketAccess, #RegulatoryAffairs and #NonClinical strategy will talk through the guide, discuss the value of a TPP and how to approach building one. Register now: https://buff.ly/3RqT2nC #TargetProductProfile #CellTherapies #GeneTherapies #TherapyDevelopers

Cell and Gene Therapy Professionals: Check out this upcoming webinar on manufacturing changes and comparability based on the recent FDA draft guidance. We'll have an excellent panel of experts to provide insight and answer your questions! https://lnkd.in/gB8rV6Rm

In this interactive roundtable—the first in a three-part series—our team discusses key opportunities, scientific innovations and insights driving acceleration of preclinical gene therapy programs to IND/CTA and beyond. Watch the roundtable here #GeneTherapy #PrecisionMedicine